GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Debt-to-Revenue

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Debt-to-Revenue : 0.73 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Zhong Yuan Bio-Technology Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $1.67 Mil. Zhong Yuan Bio-Technology Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.64 Mil. Zhong Yuan Bio-Technology Holdings's annualized Revenue for the quarter that ended in Sep. 2023 was $3.16 Mil. Zhong Yuan Bio-Technology Holdings's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was 0.73.


Zhong Yuan Bio-Technology Holdings Debt-to-Revenue Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Debt-to-Revenue Chart

Zhong Yuan Bio-Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial 0.17 0.59 1.04 0.72 1.22

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 0.60 1.34 1.11 0.73

Competitive Comparison of Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue

For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue falls into.



Zhong Yuan Bio-Technology Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.438 + 0.596) / 1.663
=1.22

Zhong Yuan Bio-Technology Holdings's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.668 + 0.64) / 3.16
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2023) Revenue data.


Zhong Yuan Bio-Technology Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
Executives
Tingting Chang director, 10 percent owner, officer: CEO RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy director, 10 percent owner, officer: president,secretary,treasurer 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: Vice President 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines